Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00953_DB01171_nanopub.RA6ySLKYM7qFaSE6OX6k7ss5SXwIV_tg_mBcsATlpxhn8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00953_DB01171 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00953_DB01171 label "DDI between Rizatriptan and Moclobemide - The MAO inhibitor, moclobemide, may decrease the metabolism and clearance of the serotonin 5-HT receptor agonist, rizatriptan. Concomitant therapy is contraindicated. [drugbank_resource:DB00953_DB01171]" assertion.
- drugbank_resource:DB00953_DB01171 identifier "drugbank_resource:DB00953_DB01171" assertion.
- drugbank_resource:DB00953_DB01171 title "DDI between Rizatriptan and Moclobemide - The MAO inhibitor, moclobemide, may decrease the metabolism and clearance of the serotonin 5-HT receptor agonist, rizatriptan. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00953 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00953_DB01171 assertion.
- drugbank:DB01171 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00953_DB01171 assertion.